Acer Therapeutics Inc
F:P6NA
Shareholder Yield
Current shareholder yield for P6NA is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
P6NA Price
Acer Therapeutics Inc
| Average Annual Return | -35.03% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -85% |
| Market Capitalization | 28.8m EUR |
| Shares Outstanding | 35 825 848 |
| Percentage of Shares Shorted |
N/A
|
P6NA Return Decomposition
Main factors of price return
Stock Splits
P6NA's latest stock split occurred on Sep 21, 2017
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, P6NA traded at 0.774 per share. Afterward, the share price was about 8.95.
The adjusted shares began trading on Sep 21, 2017. This was P6NA's 2nd stock split, following the previous one in Sep 29, 2015.
